Return On Equity of Aspire Biopharma Holdings, Inc. from 31 Mar 2021 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
Aspire Biopharma Holdings, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2021 to 31 Dec 2025.
- Aspire Biopharma Holdings, Inc. Return On Equity for the quarter ending 31 Dec 2025 was 277%, a 77% increase year-over-year.
- Aspire Biopharma Holdings, Inc. annual Return On Equity for 2025 was 277%, a 77% increase from 2024.
- Aspire Biopharma Holdings, Inc. annual Return On Equity for 2024 was 156%.
- Aspire Biopharma Holdings, Inc. annual Return On Equity for 2023 was -169%, a 381% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Aspire Biopharma Holdings, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | 277% | +121% | +77% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | 269% | +148% | +123% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | 380% | +243% | +177% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | 629% | +1328% | 01 Jan 2025 | 31 Mar 2025 | |
| Q4 2024 | 156% | +325% | 01 Oct 2024 | 31 Dec 2024 | |
| Q3 2024 | 120% | +257% | 01 Jul 2024 | 30 Sep 2024 | |
| Q2 2024 | 137% | +245% | 01 Apr 2024 | 30 Jun 2024 | |
| Q1 2024 | -699% | -635% | -987% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -169% | -134% | -381% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -137% | -121% | -765% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -108% | -108% | -29533% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -64% | -69% | -1467% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -35% | +270% | +88% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -16% | +165% | +91% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -0.36% | +15% | +98% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | 4.7% | +44% | 01 Jan 2022 | 31 Mar 2022 | |
| Q4 2021 | -305% | 01 Oct 2021 | 31 Dec 2021 | ||
| Q3 2021 | -181% | 01 Jul 2021 | 30 Sep 2021 | ||
| Q2 2021 | -15% | 01 Apr 2021 | 30 Jun 2021 | ||
| Q1 2021 | -39% | 09 Feb 2021 | 31 Mar 2021 |
Aspire Biopharma Holdings, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | 277% | +121% | +77% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | 156% | +325% | 01 Jan 2024 | 31 Dec 2024 | |
| 2023 | -169% | -134% | -381% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -35% | +270% | +88% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -305% | 09 Feb 2021 | 31 Dec 2021 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.